News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke
11 Sep 2024
byAudrey Abella
The use of tenecteplase in the extended time window of 4.5–24 hours improves functional outcomes in patients with ischaemic stroke when endovascular thrombectomy (EVT) is not immediately available, findings from the phase III TRACE-III* trial suggest.
11 Sep 2024

Antidepressant nonresponders may benefit from rTMS
10 Sep 2024
Repetitive transcranial magnetic stimulation (rTMS) demonstrates greater reduction in depressive symptoms than switching of antidepressant medications in patients with moderately treatment-resistant depression, reveals a study.
10 Sep 2024

Ustekinumab biosimilar SB17 boasts similar efficacy, safety in psoriasis
10 Sep 2024
byStephen Padilla
SB17, a proposed ustekinumab (UST) biosimilar, demonstrates comparable efficacy, safety, and pharmacokinetics (PK) to the reference drug, as well as lower immunogenicity up to week 28, among individuals suffering from moderate-to-severe psoriasis, according to a study.
10 Sep 2024





